Skip to the page
The performance
peptide guide

Bring your performance goal into the conversation.

Word in play / Compounding

Made to order needs a reason.

When an offer says “compounded,” ask what is being changed and why that change matters for your care.

Jump to a section
Compounding
Compounding prepares a medicine for an order. It differs from supplying a drug maker’s finished product.

Compare the review

Made to order does not mean FDA-approved.

FDA is an agency responsible for medicine reviews. The letters stand for Food and Drug Administration.

Ready-made medicine

As of September 2026, FDA had reviewed an approved medicine for the uses listed on its label.

Ask: which approved medicine is this?

Prepared to order

As of September 2026, compounded medicines reach patients without FDA first checking their safety, quality, or how well they work.

Ask: why is an approved product unable to meet my need?

As of September 2026, neither a prescription nor a pharmacy’s licence made a medicine prepared to order FDA-approved.

FDA says a made-to-order medicine may address a patient’s need when an approved medicine cannot.

For example, a patient may need a medicine without a dye they are allergic to, or a liquid because they cannot swallow a tablet.

FDA: what compounding means

Read the parts about patient needs and the difference in review.

The rules on copies

Ask what allows this medicine to be made.

As of September 2026, federal law allowed medicines to be made to order through two routes, each with its own conditions. One route permits a licensed pharmacy or doctor to prepare medicine on a valid prescription for an identified patient. The other covers a facility that makes batches, often for clinics. It is registered with FDA, meaning its details are recorded with the agency.

For an ordinary pharmacy using a raw ingredient, federal law sets three possible checks. If an official quality standard exists, the ingredient must meet it. Without such a standard, the ingredient must be contained in an approved medicine. When both of those options are absent, the federal list of extra ingredients permitted for compounding must include it.

Ask the pharmacy which ingredient check it meets and to show you the supporting record.

As of September 2026, federal law restricted copies of ready-made medicines already available. Ordinary pharmacies and doctors could not make these regularly or in large amounts. A copy here means a medicine that is much the same as the ready-made one.

The health professional who writes your prescription is the prescriber.

The rule for ordinary pharmacies makes an exception for a change that matters for one named patient. The prescriber must decide that it makes a significant difference compared with the ready-made medicine. A lower price does not count as that difference.

Ask the prescriber to write down the change and why it matters for you. That answer still needs to fit the other rules, including the ingredient checks.

As of September 2026, shots containing semaglutide or tirzepatide were not on FDA’s national shortage list. These medicines are used for type 2 diabetes or weight loss, under brands including Ozempic, Wegovy, Mounjaro, and Zepbound.

A local pharmacy’s empty shelf does not establish an FDA-listed shortage across the country.

  • What change do I need, and why?
  • Which rule allows this pharmacy to use this ingredient and make this medicine?
  • Which ready-made medicines were considered first?

Who prepares it?

Get the name behind the medicine.

FDA points out that an online-service patient may be unaware of who prepared the medicine.

Ask for that name before paying. Keep it beside the prescriber’s name in your notes.

Check the names and records

Carry this question forward

Who will decide about your medicine, and how will they get enough information about your health?

Understand remote care